Bayer advances Radiology development portfolio and fosters innovation in AI

Abstract: No 6096, Session No R5A-SPNRBerlin, November 22, 2022 – Bayer moves ahead with the advancement of its comprehensive Radiology portfolio with progress on the development pipeline of new contrast agents as well as further partnerships in its digital business. The company announced today the presentation of new early clinical data for gadoquatrane…
Read More